ArticleHead and neck pathology2026
Predicting Metastatic Potential from Histopathological Whole Slide Images of Primary Tumors in Head and Neck Squamous Cell Carcinoma Using Attention-Based Deep Learning and Signaling Pathway Alterations.
Article in Head and neck pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHead and Neck Squamous Cell Carcinoma (HNSCC) ranks as the 6th most prevalent cancer worldwide, imposing a significant burden on global healthcare systems. The progression to metastasis poses a substantial challenge in the clinical management of HNSCC and is a leading cause of patient mortality. Patients diagnosed with distant metastasis (DM) often have limited treatment options and predominantly receive palliative care. Therefore, timely detection of HNSCC patients at risk of metastasis is paramount for proactive intervention and close monitoring, offering the potential for early-stage treatments and enhancing patient survival rates.
methodsThe pre-processing of Whole Slide Images (WSIs) involved patching, segmentation, background removal, and color normalization. A novel diagnostic framework was introduced using deep learning to predict the likelihood of DM in patients with HNSCC. The proposed model integrates a Self-Attention mechanism with a Residual Network (ResNet), enhancing performance and addressing challenges arising from patch-level variability during pre-processing.
resultsThe proposed model outperformed convolutional neural networks (CNNs), ensemble methods, and classical classifiers such as multilayer perceptrons (MLPs) and logistic regression. It achieved an accuracy of 82.14%, an AUC of 0.80, and an F1 score of 0.82 in predicting metastasis. Robustness and generalizability were further confirmed through stratified 10-fold cross-validation on the TCGA-HNSCC dataset and external validation on the TCGA-ESCA dataset, demonstrating consistent performance across diverse patient subgroups and cancer types.
conclusionsThe proposed framework showcases potential of using Deep Learning in enhancing clinical decision-making. These findings highlight the use of attention-based models when integrated with deep residual networks offering insights for oncological diagnostics. Future work may focus on improving explainability and interpretability, incorporating multimodal data, and generalizing the approach to other cancer types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.